Aspen in talks to make and sell J&J vaccines for Africa

Africa aims to vaccinate 60% of its adult population by 2022

05 September 2021 - 00:09 By

Aspen Pharmacare says it is in talks to make Johnson & Johnson's coronavirus shot under licence in SA, at what would be Africa's first major independent distribution base for a global vaccine against Covid-19.

News of the talks coincided with the suspension of the heavily criticised shipment to Europe from Africa of the same shot, which is already being made under contract and packaged by Aspen, but distributed by J&J...

This article is reserved for Sunday Times subscribers.

A subscription gives you full digital access to all Sunday Times content.

Already subscribed? Simply sign in below.

Registered on the BusinessLIVE, Business Day or Financial Mail websites? Sign in with the same details.

Questions or problems? Email or call 0860 52 52 00.